BMO's Evan Seigerman on GLP-1 developments, state of weight-loss drug battle

Evan Seigerman, BMO Capital Markets senior pharma analyst, joins 'Squawk Box' to discuss the state of the pharma sector, latest GLP-1 developments, weight-loss drug market competition, and more.